Second Leading Independent Proxy Advisory Firm Glass Lewis Recommends Paratek Pharmaceuticals Stockholders Vote FOR the Acquisition by Gurnet Point Capital and Novo Holdings A/S

<p>Follows the recommendation from ISS to vote FOR the transaction BOSTON, Sept. 12, 2023 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (“Paratek”) (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel therapies for life-threatening diseases and other public health threats, today announced that a second leading independent proxy advisor Glass, Lewis […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/second-leading-independent-proxy-advisory-firm-glass-lewis-recommends-paratek-pharmaceuticals-stockholders-vote-for-the-acquisition-by-gurnet-point-capital-and-novo-holdings-a-s/">Second Leading Independent Proxy Advisory Firm Glass Lewis Recommends Paratek Pharmaceuticals Stockholders Vote FOR the Acquisition by Gurnet Point Capital and Novo Holdings A/S</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>